STACEY ANDERSON: Open Payments
NPI 1013300896 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,523 in 98 payments from 12 companies in 2025. Trend: 2023 $928 · 2024 $1,135 · 2025 $1,523
Food & beverage: $1,439Education: $84
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 17 | $334 |
| ABBVIE INC. | 19 | $241 |
| Madrigal Pharmaceuticals | 17 | $200 |
| Lilly USA, LLC | 11 | $198 |
| QOL Medical, LLC | 7 | $191 |
| Phathom Pharmaceuticals, Inc. | 17 | $116 |
| GENZYME CORPORATION | 4 | $94 |
| Ardelyx, Inc. | 2 | $50 |
| Regeneron Healthcare Solutions, Inc. | 1 | $35 |
| Aimmune Therapeutics, Inc. | 1 | $22 |
Products named: TREMFYA, REZDIFFRA, Sucraid, OMVOH, RINVOQ, DUPIXENT, VOQUEZNA, STELARA.
Industry payments across KY — which companies pay providers there.
